Estro-progestinic replacement therapy modulates the levels of basic fibroblast growth factor (bFGF) in postmenopausal endometrium.
Rusnati M, Casarotti G, Pecorelli S, Ragnotti G, Presta M.
Rusnati M, et al.
Gynecol Oncol. 1993 Jan;48(1):88-93. doi: 10.1006/gyno.1993.1014.
Gynecol Oncol. 1993.
PMID: 8423027
The levels of basic fibroblast growth factor (bFGF) in human endometrium do not vary during the ovulatory cycle but they increase significantly after menopause (M. Rusnati et al., Growth Factors, 3, 299-307, 1990). Here we report that cyclic estro-progestinic replac …
The levels of basic fibroblast growth factor (bFGF) in human endometrium do not vary during the ovulatory cycle but they increase significan …